This video is featured in the 2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: Fruquintinib in Refractory mCRC - Subgroup Analysis of the FRESCO-2 Trial

51 views
October 1, 2024
Comments 0
Login to view comments. Click here to Login